Literature DB >> 20190974

Efficacy of a 5-day extended therapy program during lactation with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus.

Jean-Philippe Roy1, Luc DesCôteaux, Denis DuTremblay, Francis Beaudry, Johanne Elsener.   

Abstract

This study determined the efficacy of a 5-day extended therapy with cephapirin sodium in dairy cows chronically infected with Staphylococcus aureus. Chronically infected cows selected from 14 dairy herds in the St-Hyacinthe region, Québec were randomly allocated to a group of 31 cows treated for 5 consecutive days with 200 mg of cephapirin per quarter BID or a group of 30 untreated control cows. Bacteriological cure was determined by 3 negative bacterial cultures at 10, 24, and 31 days after treatment. The cow cure rates were 25.8% (8/31) in the treated cows and 3.3% (1/30) in the control group (P = 0.013). The quarter cure rates at first sampling post-treatment were 77.6% (38/49) and 18% (9/50) in the treated and the control groups, respectively (P < 0.0001). A 5-day extended therapy with cephapirin is effective in treating cows chronically infected with S. aureus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20190974      PMCID: PMC2777288     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  12 in total

1.  A comparative randomized field trial on intramammary and intramuscular dry cow antibiotic treatment of subclinical Staphylococcus aureus mastitis in dairy cows.

Authors:  N Y Shpigel; P H Kass; A Saran
Journal:  J Vet Med A Physiol Pathol Clin Med       Date:  2006-10

2.  Factors affecting cure and somatic cell count after pirlimycin treatment of subclinical mastitis in lactating cows.

Authors:  H A Deluyker; S N Van Oye; J F Boucher
Journal:  J Dairy Sci       Date:  2005-02       Impact factor: 4.034

3.  Efficacy of extended pirlimycin hydrochloride therapy for treatment of environmental Streptococcus spp and Staphylococcus aureus intramammary infections in lactating dairy cows.

Authors:  Barbara E Gillespie; Hugh Moorehead; Phillip Lunn; Henry H Dowlen; David L Johnson; Ken C Lamar; Mark J Lewis; Susan J Ivey; John W Hallberg; S Ted Chester; Stephen P Oliver
Journal:  Vet Ther       Date:  2002

Review 4.  Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis.

Authors:  H W Barkema; Y H Schukken; R N Zadoks
Journal:  J Dairy Sci       Date:  2006-06       Impact factor: 4.034

5.  Survey of the incidence and aetiology of mastitis on dairy farms in England and Wales.

Authors:  A J Bradley; K A Leach; J E Breen; L E Green; M J Green
Journal:  Vet Rec       Date:  2007-02-24       Impact factor: 2.695

6.  Efficacy of intramammary tilmicosin and risk factors for cure of Staphylococcus aureus infection in the dry period.

Authors:  R T Dingwell; K E Leslie; T F Duffield; Y H Schukken; L DesCoteaux; G P Keefe; D F Kelton; K D Lissemore; W Shewfelt; P Dick; R Bagg
Journal:  J Dairy Sci       Date:  2003-01       Impact factor: 4.034

7.  Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows.

Authors:  S P Oliver; B E Gillespie; S J Headrick; H Moorehead; P Lunn; H H Dowlen; D L Johnson; K C Lamar; S T Chester; W M Moseley
Journal:  J Dairy Sci       Date:  2004-08       Impact factor: 4.034

Review 8.  Production effects related to mastitis and mastitis economics in dairy cattle herds.

Authors:  Henri Seegers; Christine Fourichon; François Beaudeau
Journal:  Vet Res       Date:  2003 Sep-Oct       Impact factor: 3.683

9.  Incidence rate of clinical mastitis on Canadian dairy farms.

Authors:  R G M Olde Riekerink; H W Barkema; D F Kelton; D T Scholl
Journal:  J Dairy Sci       Date:  2008-04       Impact factor: 4.034

10.  Factors associated with bacteriological cure after dry cow treatment of subclinical staphylococcal mastitis with antibiotics.

Authors:  J Sol; O C Sampimon; J J Snoep; Y H Schukken
Journal:  J Dairy Sci       Date:  1994-01       Impact factor: 4.034

View more
  4 in total

1.  Efficacy of extended intramammary ceftiofur therapy against mild to moderate clinical mastitis in Holstein dairy cows: a randomized clinical trial.

Authors:  Geoffrey Truchetti; Emile Bouchard; Luc Descôteaux; Daniel Scholl; Jean-Philippe Roy
Journal:  Can J Vet Res       Date:  2014-01       Impact factor: 1.310

2.  Elimination kinetics of ceftiofur hydrochloride in milk after an 8-day extended intramammary administration in healthy and infected cows.

Authors:  Rongwei Han; Songli Li; Jun Wang; Zhongna Yu; Jiaqi Wang; Nan Zheng
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

3.  In vitro antibiotic susceptibility and biofilm production of Staphylococcus aureus isolates recovered from bovine intramammary infections that persisted or not following extended therapies with cephapirin, pirlimycin or ceftiofur.

Authors:  Céline Ster; Valérie Lebeau; Julia Leclerc; Alexandre Fugère; Koui A Veh; Jean-Philippe Roy; François Malouin
Journal:  Vet Res       Date:  2017-09-21       Impact factor: 3.683

4.  Enhanced Treatment Effects of Tilmicosin Against Staphylococcus aureus Cow Mastitis by Self-Assembly Sodium Alginate-Chitosan Nanogel.

Authors:  Kaixiang Zhou; Xiaofang Wang; Dongmei Chen; Yuanyuan Yuan; Shuge Wang; Chao Li; Yuanyuan Yan; Qianying Liu; Liwei Shao; Lingli Huang; Zonghui Yuan; Shuyu Xie
Journal:  Pharmaceutics       Date:  2019-10-12       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.